Marc S. Lener

Процитировано

	Все	Начиная с 2020 г.
Статистика цитирования	1638	1050
h-индекс	14	13
i10-индекс	14	13

240

120

180

20112012201320142015201620172018201920202021202220232024202510 8 13 15 23 51 90 153 189 226 233 220 198 147 25

Общий доступ

Просмотреть все

13 статей

2 статьи

доступно

недоступно

На основе финансирования

Соавторы

Carlos ZarateNational Institute of Mental HealthПодтвержден адрес электронной почты в домене mail.nih.gov
Elizabeth BallardNational Institute of Mental Health/National Institutes of Health Подтвержден адрес электронной почты в домене nih.gov
Mark J. NiciuAssistant Professor of Psychiatry, University of IowaПодтвержден адрес электронной почты в домене uiowa.edu
Allison NugentNIHПодтвержден адрес электронной почты в домене mail.nih.gov
dennis charneyicahn schoold of medicine at mount sinaiПодтвержден адрес электронной почты в домене mssm.edu
Cheuk Ying TangMount Sinai School of MedicineПодтвержден адрес электронной почты в домене dentistry.ucla.edu
Rebecca PriceAssociate Professor of Psychiatry and Psychology, University of PittsburghПодтвержден адрес электронной почты в домене upmc.edu
wayne goodmanBaylor College of MedicineПодтвержден адрес электронной почты в домене bcm.edu
Jessica SternDrexel UniversityПодтвержден адрес электронной почты в домене drexel.edu
Thomas M. HydeChief Operating Officer, Lieber Institute for Brain DevelopmentПодтвержден адрес электронной почты в домене libd.org
Daniel R. WeinbergerLieber Institute for Brain DevelopmentПодтвержден адрес электронной почты в домене libd.org
William ByneColumbia University Vagelos College of Physicians and Surgeons & NY State Psychiatric InstituteПодтвержден адрес электронной почты в домене cumc.columbia.edu
Harold KoenigsbergProfessor of Psychiatry, Icahn School of Medicine at Mount SinaiПодтвержден адрес электронной почты в домене mssm.edu
Prantik Kundu, PhDCeretype Neuromedicine Inc., Mount Sinai School of Medicine, Brigham and Women's Hospital, HMSПодтвержден адрес электронной почты в домене ceretype.com
Konasale PrasadUniversity of PittsburghПодтвержден адрес электронной почты в домене pitt.edu
Matcheri KeshavanProfessor of Psychiatry, Harvard UniversityПодтвержден адрес электронной почты в домене bidmc.harvard.edu
Michael K. ParidesHospital for Special SurgeryПодтвержден адрес электронной почты в домене hss.edu
Joonsuk KimBroadcomПодтвержден адрес электронной почты в домене ieee.org

Marc S. Lener

National Institute of Mental Health

Подтвержден адрес электронной почты в домене nih.gov

Psychiatry


Название По числу цитат По году По названию	Процитировано Процитировано	Год
Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine MS Lener, MJ Niciu, ED Ballard, M Park, LT Park, AC Nugent, ... Biological psychiatry 81 (10), 886-897, 2017	476	2017
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial JW Murrough, L Soleimani, KE DeWilde, KA Collins, KA Lapidus, ... Psychological medicine 45 (16), 3571-3580, 2015	340	2015
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression. ZC Lener MS, Kadriu B Drugs, 2017	133	2017
In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature MS Lener, DV Iosifescu Annals of the New York Academy of Sciences 1344 (1), 50-65, 2015	120	2015
White matter abnormalities in schizophrenia and schizotypal personality disorder MS Lener, E Wong, CY Tang, W Byne, KE Goldstein, NJ Blair, ... Schizophrenia bulletin 41 (1), 300-310, 2015	93	2015
Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales ED Ballard, JS Yarrington, CA Farmer, MS Lener, B Kadriu, N Lally, ... Journal of affective disorders 231, 51-57, 2018	90	2018
Handedness, heritability, neurocognition and brain asymmetry in schizophrenia A Deep-Soboslay, TM Hyde, JP Callicott, MS Lener, BA Verchinski, ... Brain 133 (10), 3113-3122, 2010	82	2010
Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder B Kadriu, PW Gold, DA Luckenbaugh, MS Lener, ED Ballard, MJ Niciu, ... Molecular psychiatry 23 (7), 1626-1631, 2018	67	2018
Cortical abnormalities and association with symptom dimensions across the depressive spectrum MS Lener, P Kundu, E Wong, KE Dewilde, CY Tang, P Balchandani, ... Journal of affective disorders 190, 529-536, 2016	58	2016
Neurophysiological changes associated with antidepressant response to ketamine not observed in a negative trial of scopolamine in major depressive disorder L Park, M Furey, AC Nugent, C Farmer, J Ellis, J Szczepanik, MS Lener, ... International Journal of Neuropsychopharmacology 22 (1), 10-18, 2019	42	2019
Frontal release signs and cognition in people with schizophrenia, their siblings and healthy controls TM Hyde, TE Goldberg, MF Egan, MC Lener, DR Weinberger The British Journal of Psychiatry 191 (2), 120-125, 2007	38	2007
A double-blind, placebo-controlled, pilot study of riluzole monotherapy for acute bipolar depression LT Park, MS Lener, M Hopkins, N Iadorola, R Machado-Vieira, E Ballard, ... Journal of clinical psychopharmacology 37 (3), 355-358, 2017	32	2017
The effects of ketamine on typical and atypical depressive symptoms LT Park, DA Luckenbaugh, SJ Pennybaker, MA Hopkins, ID Henter, ... Acta Psychiatrica Scandinavica 142 (5), 394-401, 2020	23	2020
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder MJ Niciu, ND Iadarola, D Banerjee, DA Luckenbaugh, M Park, M Lener, ... Journal of Psychopharmacology 31 (12), 1570-1577, 2017	22	2017
RGS4 and COMT risk variants are associated with brain structural alterations MS Lener, SJ Goodnow, JA Wood, KV Chowdari, MS Keshavan, ... Schizophrenia research 150 (1), 321, 2013	6	2013
Clinical trial of the potassium channel activator diazoxide for major depressive disorder halted due to intolerability B Kadriu, S Yuan, C Farmer, AC Nugent, MS Lener, MJ Niciu, M Park, ... Journal of clinical psychopharmacology 38 (3), 243-246, 2018	5	2018
330. A Principal Components Analysis of Depression and Anhedonia Scales: Illustrating the Heterogeneity of Depression E Ballard, D Luckenbaugh, J Yarrington, N Lally, M Lener, ... Biological Psychiatry 81 (10), S135, 2017	4	2017
RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ketamine L Park, M Furey, A Nugent, C Farmer, J Ellis, J Szczepanik, M Lener, ... Biological Psychiatry 83 (9), S305-S306, 2018	3	2018
1003. Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depression B Kadriu, P Gold, M Lener, E Ballard, M Niciu, P Yuan, D Luckenbaugh, ... Biological Psychiatry 81 (10), S405-S406, 2017	1	2017
517. Effects of Ketamine on Atypical and Typical Symptoms of Depression K Yu, L Park, D Luckenbaugh, S Pennybaker, M Hopkins, M Lener, ... Biological Psychiatry 81 (10), S210, 2017	1	2017

В данный момент система не может выполнить эту операцию. Повторите попытку позднее.

Статьи 1–20

Ссылок за год

Повторяющиеся цитирования

Объединенные цитирования

СоавторыСоавторы

Подписаться

Процитировано

Соавторы